The operational and strategic needs of labs are continuously changing, evolving, and expanding with the rising pharmaceutical industry’s R&D to discover novel drugs and therapies. The increasing funding for genomics and proteomics research is augmenting the need for automated, replicable, and accurate solutions to aid diagnostics/clinical research and to offset the lack of highly skilled laboratory professionals. This is where automated plate readers, including microplate readers, work to quantify protein and other activities via a specific light source connected through an optical filter for analyzing the sample.
Microplate readers in recent years are selected as a technical choice in the high-throughput screening for quantitative biology. The manufacturers are focusing on developing advanced microplate readers that help scientists, from academic labs to fast-paced biotechnology organizations, advance their research.
In June 2022, Molecular Devices, LLC launched SpectraMax® Mini Multi-Mode Microplate Reader to save researchers benchtop space and budget. Along with this, the innovators are upgrading mini microplate readers that feature three detection modes for fluorescence, UV-Visible absorbance, and luminescence.
The ongoing innovations and changing operational needs of laboratories and pharmaceutical companies, mini microplate readers are gaining popularity, which provide ease of use and flexibility for a broad range of research and life sciences.